Intravenous immunoglobulin improves clinical outcome in Churg-Strauss syndrome
- Consultant Respiratory Physician, S P Fort Hospital, Trivandrum, India; arjun_p@vsnl.com
Churg-Strauss Syndrome (CSS) is a necrotising vasculitis of medium and small sized vessels clinically characterised by asthma, eosinophilia, and systemic vasculitis associated with circulating antibodies to antineutrophil cytoplasmic antigen (ANCA). The standard treatment of this condition comprises corticosteroids and, in severe cases, cytotoxic drugs. However, this treatment protocol is associated with a high relapse rate and significant drug …









